Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey

The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not...

Descripción completa

Detalles Bibliográficos
Autores: Hoste, Levi, MIS-C researchers, Soriano-Arandes, Antoni, Buddingh, Emilie Pauline, Belot, Alexandre, Ulloa-Gutiérrez, Rolando, Olbrich, Peter, Haerynck, Filomeen
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/279790
Acceso en línea:http://hdl.handle.net/10261/279790
Access Level:acceso abierto
Palabra clave:MIS-C
SARS-CoV-2
COVID-19
Vaccinationadverse events
Descripción
Sumario:The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.

Similares en LA Referencia